Risk of sales and profit concentration in March
First written in FY2016. 8 of 9 entries say "Restated". Latest entry: FY2026.
The whole theme swung hardest in 2019: 1 of 8 companies on the "Worse" side.
4 other companies' latest entry also says "Restated".
- FY2026RestatedAnnual report
「Sales 1,806 2,089 2,091 2,386 Operating profit 558 845 728 792 Ordinary profit 588 862 793 829」
In the fiscal year ended March 2026, fourth-quarter sales were ¥2,386 million, operating profit was ¥792 million and ordinary profit was ¥829 million, numerically reconfirming the concentration of business performance in the fourth quarter, including March. - FY2024RestatedAnnual report
「Acceptance inspections by user companies for customized packaged software and commissioned development projects are concentrated in March. If acceptance inspections are delayed, sales and profit recognition may shift into the following fiscal year.」
The company has reconfirmed the risk that sales and profit concentrated in March may shift into the following fiscal year due to delayed acceptance inspections. In the fiscal year ended March 2024, fourth-quarter sales were ¥1,900 million and operating profit was ¥647 million. - FY2023RestatedAnnual report
「Acceptance inspections by user companies for customized packaged software and commissioned development projects are concentrated in March. If acceptance inspections are delayed, sales and profit may be recognized in the following fiscal year.」
The company has reconfirmed the risk that sales and profit concentrated in March may shift into the following fiscal year due to delayed acceptance inspections. In the fiscal year ended March 2023, fourth-quarter sales were ¥1,729 million and operating profit was ¥518 million. - FY2022RestatedAnnual report
「Acceptance inspections by user companies for customized packaged software and commissioned development projects are concentrated in March. If acceptance inspections are delayed, sales and profit may be recognized in the following fiscal year.」
The company has reconfirmed the risk that sales and profit concentrated in March may shift into the following fiscal year due to delayed acceptance inspections. In the fiscal year ended March 2022, fourth-quarter sales were ¥1,975 million and operating profit was ¥664 million. - FY2021RestatedAnnual report
「Sales 940 1,211 1,076 2,123 Operating profit 178 393 360 788」
In the fiscal year ended March 2021, fourth-quarter sales were ¥2,123 million and operating profit was ¥788 million, reconfirming through quarterly figures the concentration of sales and profit in March. - FY2019RestatedAnnual report
「Many user companies want new systems for accounting and other business operations to be operational from the start of the new fiscal year. Because the fiscal year-end month of many companies in Japan is concentrated in March, the Group’s business performance tends to show particularly high sales and profit levels in March compared with other months.」
In the fiscal year ended March 2019, fourth-quarter sales were ¥1,543 million and operating profit was ¥706 million, numerically reconfirming the concentration of sales and profit in March. - FY2018RestatedAnnual report
「In the first quarter of the fiscal year ended March 2018, sales were ¥857 million and operating profit was ¥204 million, compared with sales of ¥1,612 million and operating profit of ¥695 million in the fourth quarter.」
The company has reconfirmed the concentration of sales and profit in March using quarterly figures for the full year. It also continues to state that delayed acceptance inspections may result in recognition in the following fiscal year. - FY2017RestatedAnnual report
「Many users want new systems for accounting and other business operations to be operational from the start of the new fiscal year. Because the fiscal year-end month of many companies in Japan is concentrated in March, the Group’s business performance tends to show particularly high sales and profit levels in March compared with other months. In addition, acceptance inspections by users for customized packaged software and commissioned development projects are concentrated in March. If acceptance inspections are delayed, sales and profit may be recognized in the following fiscal year.」
The company shows the risk of concentration in March together with full-year quarterly results of sales of ¥701 million, ¥1,022 million, ¥953 million and ¥1,434 million, and operating profit of ¥158 million, ¥335 million, ¥345 million and ¥705 million. - FY2016First statedAnnual report
「The Group’s business performance tends to show particularly high sales and profit levels in March compared with other months.」
The company also notes that because new fiscal-year operations and acceptance inspections are concentrated in March, delays in acceptance inspections may shift sales and profit recognition into the following fiscal year.